Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated active pharmaceutical ingredients (APIs) where the trifluoromethyl group enhances metabolic stability and bioavailability. Its bromoaryl structure allows for further functionalization via cross-coupling reactions, making it valuable in medicinal chemistry for building complex molecules. Also employed in the preparation of agrochemicals and specialty materials requiring enhanced lipophilicity and resistance to degradation.